Radiopharmaceuticals for PET and SPECT imaging: a literature review over the last decade

G Crișan, NS Moldovean-Cioroianu… - International journal of …, 2022 - mdpi.com
Positron emission tomography (PET) uses radioactive tracers and enables the functional
imaging of several metabolic processes, blood flow measurements, regional chemical …

PARP inhibitors in cancer diagnosis and therapy

CY Chan, KV Tan, B Cornelissen - Clinical Cancer Research, 2021 - AACR
Targeting of PARP enzymes has emerged as an effective therapeutic strategy to selectively
target cancer cells with deficiencies in homologous recombination signaling. Currently used …

[HTML][HTML] The promise of metabolic imaging in diffuse midline glioma

S Lovibond, AN Gewirtz, L Pasquini, S Krebs… - Neoplasia, 2023 - Elsevier
Recent insights into histopathological and molecular subgroups of glioma have
revolutionized the field of neuro-oncology by refining diagnostic categories. An emblematic …

Current status and progress in using radiolabelled PARP-1 inhibitors for imaging PARP-1 expression in tumours

Q Wang, J Zhang - European Journal of Medicinal Chemistry, 2022 - Elsevier
Abstract Poly (ADP-ribose) polymerase-1 (PARP-1) is a key enzyme in the DNA repair
process, and the overexpression of PARP-1 in several tumours makes this enzyme a …

A phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer

P Demetrio de Souza Franca, S Kossatz… - European journal of …, 2021 - Springer
Background Visual inspection and biopsy is the current standard of care for oral cancer
diagnosis, but is subject to misinterpretation and consequently to misdiagnosis. Topically …

DoE Optimization Empowers the Automated Preparation of Enantiomerically Pure [18F]Talazoparib and its In Vivo Evaluation as a PARP Radiotracer

GD Bowden, S Stotz, J Kinzler, C Geibel… - Journal of Medicinal …, 2021 - ACS Publications
Given the clinical potential of poly (ADP-ribose) polymerases (PARP) imaging for the
detection and stratification of various cancers, the development of novel PARP imaging …

DNA damage response and repair in the development and treatment of brain tumors

PM Dana, F Sadoughi, H Mirzaei, Z Asemi… - European Journal of …, 2022 - Elsevier
DNA damage response (DDR) comprising DNA repair and cell-cycle checkpoint pathways,
is considered as a protective process that maintains the integrity of the genome. However …

[123I] CC1: a PARP-targeting, Auger electron–emitting radiopharmaceutical for radionuclide therapy of cancer

CY Chan, Z Chen, F Guibbal, G Dias… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Poly (adenosine diphosphate ribose) polymerase (PARP) has emerged as an effective
therapeutic strategy against cancer that targets the DNA damage repair enzyme. PARP …

Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer

SLV Hoffman, JC Mixdorf, O Kwon, TR Johnson… - Nuclear Medicine and …, 2023 - Elsevier
Advanced ovarian cancer currently has few therapeutic options. Poly (ADP-ribose)
polymerase (PARP) inhibitors bind to nuclear PARP and trap the protein-inhibitor complex to …

Advances in Neuro-Oncological imaging: an update on Diagnostic Approach to Brain tumors

P Sabeghi, P Zarand, S Zargham, B Golestany… - Cancers, 2024 - mdpi.com
Simple Summary In the realm of neurology, advanced imaging tools play a crucial role as
critical endpoints in clinical trials. While magnetic resonance imaging (MRI) serves as a …